Spectrum and Outcome of Primary Cardiomyopathies Diagnosed During Fetal Life

JACC: Heart Failure

Volumn 2, Issue 4, 2014, Pages 403-411

  Weber, Roland ^a   Kantor, Paul ^a   Chitayat, David ^b   Friedberg, Mark K ^a   Golding, Fraser ^a   Mertens, Luc ^a   Nield, Lynne E ^a   Ryan, Greg ^b   Seed, Mike ^a   Yoo, Shi Joon ^a   Manlhiot, Cedric ^a   Jaeggi, Edgar ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cardiomyopathy; Echocardiography; Fetal; Noncompaction; Outcome

Indexed keywords

ARTICLE; CARDIOMYOPATHY; CARDIOTHORACIC AREA RATIO; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR PROFILE SCORE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; FETUS; FETUS MORTALITY; FETUS OUTCOME; FETUS RISK; GESTATIONAL AGE; HEART VENTRICLE WALL; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; MAJOR CLINICAL STUDY; NONHYPERTROPHIC CARDIOMYOPATHY; OUTCOME ASSESSMENT; PHENOTYPE; PREDICTOR VARIABLE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SINUS RHYTHM; CARDIOMYOPATHIES; EMBRYOLOGY; FEMALE; FETAL DISEASES; HEART DEFECTS, CONGENITAL; KAPLAN MEIER METHOD; MORTALITY; PREGNANCY; PREGNANCY OUTCOME;

CARDIOMYOPATHIES; FEMALE; FETAL DISEASES; HEART DEFECTS, CONGENITAL; HUMANS; KAPLAN-MEIER ESTIMATE; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES;

EID: 84905459431     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2014.02.010     Document Type: Article

References (34)

1. Towbin J.A., Lowe A.M., Colan S.D., et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 2006, 296:1867-1876.
2. Arola A., Jokinen E., Ruuskanen O., et al. Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. Am J Epidemiol 1997, 146:385-393.
3. Nugent A.W., Daubeney P.E., Chondros P., et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 2003, 348:1639-1646.
4. Lipshultz S.E., Sleeper L.A., Towbin J.A., et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003, 348:1647-1655.
5. Grenier M.A., Osganian S.K., Cox G.F., et al. Design and implementation of the North American Pediatric Cardiomyopathy Registry. Am Heart J 2000, 139:S86-S95.
6. Cox G.F., Sleeper L.A., Lowe A.M., et al. Factors associated with establishing a causal diagnosis for children with cardiomyopathy. Pediatrics 2006, 118:1519-1531.
7. Boucek M.M., Waltz D.A., Edwards L.B., et al. Registry of the International Society for Heart and Lung Transplantation: ninth official pediatric heart transplantation report-2006. J Heart Lung Transplant 2006, 25:893-903.
8. Pedra S.R., Smallhorn J.F., Ryan G., et al. Fetal cardiomyopathies: pathogenic mechanisms, hemodynamic findings, and clinical outcome. Circulation 2002, 106:585-591.
9. Van Mieghem T., Martin A.M., Weber R., et al. Fetal cardiac function in recipient twins undergoing fetoscopic laser ablation of placental anastomoses for Stage IV twin-twin transfusion syndrome. Ultrasound Obstet Gynecol 2013, 42:64-69.
10. Jaeggi E.T., Fouron J.C., Proulx F. Fetal cardiac performance in uncomplicated and well-controlled maternal type I diabetes. Ultrasound Obstet Gynecol 2001, 17:311-315.
11. Schneider C., McCrindle B.W., Carvalho J.S., Hornberger L.K., McCarthy K.P., Daubeney P.E. Development of Z-scores for fetal cardiac dimensions from echocardiography. Ultrasound Obstet Gynecol 2005, 26:599-605.
12. Huhta J.C. Fetal congestive heart failure. Semin Fetal Neonat Med 2005, 10:542-552.
13. Eidem B.W., Edwards J.M., Cetta F. Quantitative assessment of fetal ventricular function: establishing normal values of the myocardial performance index in the fetus. Echocardiography 2001, 18:9-13.
14. Van Mieghem T., Gucciardo L., Done E., et al. Left ventricular cardiac function in fetuses with congenital diaphragmatic hernia and the effect of fetal endoscopic tracheal occlusion. Ultrasound Obstet Gynecol 2009, 34:424-429.
15. Richardson P., McKenna W., Bristow M., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996, 93:841-842.
16. Elliott P., Andersson B., Arbustini E., et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008, 29:270-276.
17. Schmidt K.G., Birk E., Silverman N.H., Scagnelli S.A. Echocardiographic evaluation of dilated cardiomyopathy in the human fetus. Am J Cardiol 1989, 63:599-605.
18. Yinon Y., Yagel S., Hegesh J., et al. Fetal cardiomyopathy-in utero evaluation and clinical significance. Prenat Diagn 2007, 27:23-28.
19. Arunamata A., Punn R., Cuneo B., Bharati S., Silverman N.H. Echocardiographic diagnosis and prognosis of fetal left ventricular noncompaction. J Am Soc Echocardiogr 2012, 25:112-120.
20. Kohli S.K., Pantazis A.A., Shah J.S., et al. Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria?. Eur Heart J 2008, 29:89-95.
21. Simchen M.J., Toi A., Silver M., et al. Fetal cardiac calcifications: report of four prenatally diagnosed cases and review of the literature. Ultrasound Obstet Gynecol 2006, 27:325-330.
22. Jaeggi E.T., Chitayat D., Taylor G. Atrial standstill associated with loss of atrial myocytes: a rare cause of fetal bradyarrhythmia. Heart Rhythm 2009, 6:1370-1372.
23. Jaeggi E.T., Fouron J.C., Silverman E.D., Ryan G., Smallhorn J., Hornberger L.K. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation 2004, 110:1542-1548.
24. Trucco S.M., Jaeggi E., Cuneo B., et al. Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy. J Am Coll Cardiol 2011, 57:715-723.
25. Cuneo B.F., Fruitman D., Benson D.W., et al. Spontaneous rupture of atrioventricular valve tensor apparatus as late manifestation of anti-Ro/SSA antibody-mediated cardiac disease. Am J Cardiol 2011, 107:761-766.
26. Sivasankaran S., Sharland G.K., Simpson J.M. Dilated cardiomyopathy presenting during fetal life. Cardiol Young 2005, 15:409-416.
27. Nield L.E., Silverman E.D., Taylor G.P., et al. Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis. Circulation 2002, 105:843-848.
28. Daubeney P.E., Nugent A.W., Chondros P., et al. Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation 2006, 114:2671-2678.
29. Freedom R.M., Jaeggi E.T., Lim J.S., Anderson R.H. Hearts with isomerism of the right atrial appendages - one of the worst forms of disease in 2005. Cardiol Young 2005, 15:554-567.
30. Maron B.J., Tajik A.J., Ruttenberg H.D., et al. Hypertrophic cardiomyopathy in infants: clinical features and natural history. Circulation 1982, 65:7-17.
31. Skinner J.R., Manzoor A., Hayes A.M., Joffe H.S., Martin R.P. A regional study of presentation and outcome of hypertrophic cardiomyopathy in infants. Heart 1997, 77:229-233.
32. Colan S.D., Lipshultz S.E., Lowe A.M., et al. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry. Circulation 2007, 115:773-781.
33. Friedberg M.K., Ursell P.C., Silverman N.H. Isomerism of the left atrial appendage associated with ventricular noncompaction. Am J Cardiol 2005, 96:985-990.
34. Karatza A.A., Holder S.E., Gardiner H.M. Isolated non-compaction of the ventricular myocardium: prenatal diagnosis and natural history. Ultrasound Obstet Gynecol 2003, 21:75-80.